Clinical trial
Safety and Immune Response of Different Pediatric Combination Vaccines.
NCT00255047 · Sanofi Pasteur, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00255047 |
|---|---|
| Title | Safety and Immune Response of Different Pediatric Combination Vaccines. |
| Official title | Comparative Immunogenicity of Different Multivalent Component Pertussis Vaccine Formulations Based on a 5 Component Acellular Pertussis Vaccine in Infants and Toddlers |
| Lead sponsor | Sanofi Pasteur, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diphtheria, Polio, Pertussis |
| Intervention type | Biological |
| Interventions | DAPTACEL®. (DTaP), IPOL®., and ActHIB®., Pentacel®: DTaP-IPV/Hib combined, DTaP-IPV and ActHIB® |
| Enrollment | 2,167 |
| Start date | Nov 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | Nov 17, 2005 |
| Last update posted | Feb 14, 2014 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: